View Author
patient study scale measure score group outcome measures trial outcome value treatment fatigue neuropathy disability neurology method difference neurol validity symptom guillain-barre syndrome merkie change health assessment ef ficacy flammatory demyelinating polyradiculoneuropathy reliability research signi rasch immune-mediated neuropathies incat flammatory threshold measurement igiv-c immune-mediated syndrome guillain-barre sfn symptoms demyelinating nerve quality system strength netherland ficacy immunoglobulin model discrimination table psychiatry neurosurg two-point neuropathie sarcoidosi polyneuropathy hughe immune-mediated polyneuropathies result ficant anchor-based brand placebo phase randomized infusion disease outcome measure effect size igiv-c group motor incat disability score ´ guillain-barre syndrome motor nerves fi rst period clinimetric gammagard kiovig
10 Most Recent Publications
|
Improving and standardising assessment of patients with immune-mediated neuropathies: Peripheral Neuropathy outcome measures Standardisation study
(PeriNomS study – part 1)
(Doctoral Thesis)
Nes, S.I. van |
2012-01-11
|
|
Revised normative values for grip strength with the Jamar dynamometer
(Article)
Peters, M.J.H. Nes, S.I. van Vanhoutte, E.K. Bakkers, M. Doorn, P.A. van Merkies, I.S.J. Faber, C.G. |
2011-03-01
|
|
Rasch-built Overall Disability Scale (R-ODS) for immune-mediated peripheral neuropathies
(Article)
Nes, S.I. van Vanhoutte, E.K. Doorn, P.A. van Hermans, M.C.E. Bakkers, M. Kuitwaard, K. Faber, C.G. Merkies, I.S.J. |
2011-01-25
|
|
Pain and autonomic dysfunction in patients with sarcoidosis and small fibre neuropathy
(Article)
Bakkers, M. Faber, C.G. Drent, M. Hermans, M.C.E. Nes, S.I. van Lauria, G. Baets, M. de Merkies, I.S.J. |
2010-12-01
|
|
Randomised controlled trial comparing two different intravenous immunoglobulins in chronic inflammatory demyelinating polyradiculoneuropathy
(Article)
Kuitwaard, K. Berg, L.H. van den Hop, W.C.J. Doorn, P.A. van Vermeulen, M. Brusse, E. Cats, E.A. Kooi, A.J. van der Notermans, N.C. Pol, W.L. van der Schaik, I.N. van Nes, S.I. van |
2010-12-01
|
|
Confirming the efficacy of intravenous immunoglobulin in CIDP through minimum clinically important differences: Shifting from statistical significance to clinical relevance
(Article)
Merkies, I.S.J. Nes, S.I. van Hanna, K. Hughes, R.A.C. Deng, C. |
2010-11-01
|
|
Improving fatigue assessment in immune-mediated neuropathies: The modified Rasch-built fatigue severity scale
(Article)
Nes, S.I. van Vanhoutte, E.K. Faber, C.G. Garssen, M.P.J. Doorn, P.A. van Merkies, I.S.J. |
2009-12-01
|
|
Intraepidermal nerve fiber density and its application in sarcoidosis
(Article)
Bakkers, M. Merkies, I.S.J. Lauria, G. Devigili, G. Penza, P. Lombardi, R. Hermans, M.C.E. Nes, S.I. van Baets, M. de Faber, C.G. |
2009-10-01
|
|
Revising two-point discrimination assessment in normal aging and in patients with polyneuropathies
(Article)
Nes, S.I. van Faber, C.G. Hamers, R.M.T.P. Harschnitz, O. Bakkers, M. Hermans, M.C.E. Meijer, R.J. Doorn, P.A. van Merkies, I.S.J. |
2008-07-01
|
|
Outcome measures in immune-mediated neuropathies: The need to standardize their use and to understand the clinimetric essentials
(Article)
Nes, S.I. van Faber, C.G. Merkies, I.S.J. |
2008-06-01
|
